Drug intelligence / Profile preview

18F-FT-FAPI

Development stage
Unknown
Lead developer
Xijing Hospital
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

18F-FT-FAPI is a positron emission tomography (PET) radiotracer designed to target fibroblast activation protein alpha (FAP), a protein highly expressed on cancer-associated fibroblasts (CAFs) within the tumor microenvironment and in various fibrotic conditions. Developed by researchers at the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University (Xijing Hospital), this tracer utilizes the fluorine-18 isotope, which offers advantages such as a longer half-life (110 minutes) compared to gallium-68, enabling centralized production and high-resolution imaging. The ligand, FT-FAPI, is a small molecule inhibitor derivative that binds with high affinity to FAP. It is currently being evaluated in clinical studies to assess its safety, biodistribution, and diagnostic utility in healthy volunteers and potentially in patients with various malignancies or fibrotic diseases.

Other names
[18F]FT-FAPI
02

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on 18F-FT-FAPI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-FT-FAPI.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call